Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

被引：37
|
作者：
Lee, Sung Won [1 ,2 ]
Choi, Jonggi [3 ]
Kim, Seung Up [4 ,5 ]
Lim, Young-Suk [3 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ, Liver Res Ctr, Seoul, South Korea
[3] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[4] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2021年 / 27卷 / 03期
关键词：
Entecavir; Tenofovir; Hepatitis B; Carcinoma; Hepatocellular; Efficacy; Outcome; DISOPROXIL FUMARATE; RISK; CIRRHOSIS;
D O I：
10.3350/cmh.2021.0179
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.
引用
收藏
页码：402 / 412
页数：11
相关论文
共 50 条
  • [41] No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir vs Tenofovir
    Oh, Hyunwoo
    Yoon, Eileen L.
    Jun, Dae Won
    Ahn, Sang Bong
    Lee, Hyo-Young
    Jeong, Jae Yoon
    Kim, Hyoung Su
    Jeong, Soung Won
    Kim, Sung Eun
    Shim, Jae-Jun
    Sohn, Joo Hyun
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2793 - +
  • [42] Hepatocellular Carcinoma Incidence In Chronic Hepatitis B Patients Under Long-Term Treatment With Entecavir And Tenofovir
    Cardoso, Helder
    Gaspar, Rui
    Silva, Marco
    Vale, Ana
    Macedo, Guilherme
    HEPATOLOGY, 2015, 62 : 961A - 961A
  • [43] Occurence of hepatocellular carcinoma in chronic hepatitis B patients undergoing entecavir or tenofovir treatment: a multicenter study in Taiwan
    Huang, Yi-Hsiang
    Yu, Ming-Lung
    Peng, Cheng-Yuan
    Liu, Chun-Jen
    Hung, Chao-Hung
    Cheng, Pin-Nan
    Chen, Jyh-Jou
    Hu, Tsung-Hui
    Lee, ChiehJu
    Chien, Rong-Nan
    JOURNAL OF HEPATOLOGY, 2020, 73 : S887 - S887
  • [44] Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B
    Yip, Terry C. F.
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Chan, Henry
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E128 - E128
  • [45] Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B
    Lee, Hye Won
    Kim, Seung Up
    HEPATOMA RESEARCH, 2022, 8
  • [46] A comparative study of risks for hepatocellular carcinoma and mortality in chronic hepatitis B patients initially treated with entecavir or tenofovir
    Lee, Hyo Young
    Yoon, Eileen
    Jun, Dae Won
    Oh, Hyunwoo
    Ahn, Sang Bong
    Jeong, Jae Yoon
    Kim, Sung Eun
    Jeong, Soung Won
    Kim, Hyoung Su
    Shim, Jae-Jun
    Sohn, Joo Hyun
    Cho, Yong Kyun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S593 - S594
  • [47] Risk of Hepatocellular Carcinoma Decreases over Time in Chronic Hepatitis B Patients on Antiviral Therapy with Entecavir or Tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-Jon
    El-Serag, Hashem B.
    Lin, Jaw-Town
    Wu, Chun-Ying
    HEPATOLOGY, 2016, 64 : 56A - 56A
  • [48] Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues
    Lampertico, Pietro
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2020, 158 (01) : 42 - 44
  • [49] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
    Ha, Yeonjung
    Chon, Young Eun
    Kim, Mi Na
    Lee, Joo Ho
    Hwang, Seong Gyu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [50] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
    Yeonjung Ha
    Young Eun Chon
    Mi Na Kim
    Joo Ho Lee
    Seong Gyu Hwang
    Scientific Reports, 10
12345